LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

Search

Legend Biotech Corp ADR

Closed

SectorHealthcare

34.61 -4.13

Overview

Share price change

24h

Current

Min

34.38

Max

35.75

Key metrics

By Trading Economics

Income

-26M

-125M

Sales

61M

256M

EPS

-0.54

Profit margin

-48.758

Employees

2,800

EBITDA

-25M

-114M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+113.33% upside

Dividends

By Dow Jones

Next Earnings

11 lis 2025

Market Stats

By TradingEconomics

Market Cap

-279M

6.4B

Previous open

38.74

Previous close

34.61

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Legend Biotech Corp ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 sie 2025, 11:06 UTC

Earnings

Legend Biotech 2Q Loss/Shr 34c >LEGN

11 sie 2025, 11:06 UTC

Earnings

Legend Biotech 2Q Loss $125.4M >LEGN

11 sie 2025, 11:00 UTC

Earnings

Legend Biotech 2Q Rev $255.1M >LEGN

13 maj 2025, 11:01 UTC

Earnings

Legend Biotech 1Q Loss/Shr 27c >LEGN

13 maj 2025, 11:00 UTC

Earnings

Legend Biotech 1Q Rev $195.1M >LEGN

11 mar 2025, 11:09 UTC

Earnings

Legend Biotech 4Q Research and Development Expenses $104.4M >LEGN

11 mar 2025, 11:08 UTC

Earnings

Legend Biotech 4Q EPS 7c >LEGN

11 mar 2025, 11:00 UTC

Earnings

Legend Biotech 4Q Rev $186.5M >LEGN

12 lis 2024, 12:06 UTC

Earnings

Legend Biotech 3Q Loss/Shr 34c >LEGN

12 lis 2024, 12:05 UTC

Earnings

Legend Biotech 3Q Net Trade Sales ABout $286M >LEGN

12 lis 2024, 12:00 UTC

Earnings

Legend Biotech 3Q Rev $160.2M >LEGN

Peer Comparison

Price change

Legend Biotech Corp ADR Forecast

Price Target

By TipRanks

113.33% upside

12 Months Forecast

Average 76.97 USD  113.33%

High 94 USD

Low 54 USD

Based on 15 Wall Street analysts offering 12 month price targets forLegend Biotech Corp ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

14

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

30.5 / 33.91Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Legend Biotech Corp ADR

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.
help-icon Live chat